A seeding-based neuronal model of tau aggregation for use in drug discovery
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283941 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Ines S Amorim und 14 weiteren Autor:innen. Beteiligte Einrichtung: SERVIER, Institut de Recherches Servier, Croissy-sur-Seine, France. Hauptthemen laut MEDLINE: Tauopathies, Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut de Recherches Servier, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique.
Abstract (Originalsprache)
Intracellular accumulation of tau protein is a hallmark of Alzheimer’s Disease and Progressive Supranuclear Palsy, as well as other neurodegenerative disorders collectively known as tauopathies. Despite our increasing understanding of the mechanisms leading to the initiation and progression of tau pathology, the field still lacks appropriate disease models to facilitate drug discovery. Here, we established a novel and modulatable seeding-based neuronal model of full-length 4R tau accumulation using humanized mouse cortical neurons and seeds from P301S human tau transgenic animals. The model shows specific and consistent formation of intraneuronal insoluble full-length 4R tau inclusions, which are positive for known markers of tau pathology (AT8, PHF-1, MC-1), and creates seeding competent tau. The formation of new inclusions can be prevented by treatment with tau siRNA, providing a robust internal control for use in qualifying the assessment of potential therapeutic candidates aimed at reducing the intracellular pool of tau. In addition, the experimental set up and data analysis techniques used provide consistent results in larger-scale designs that required multiple rounds of independent experiments, making this is a versatile and valuable cellular model for fundamental and early pre-clinical research of tau-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SERVIER, Institut de Recherches Servier, Croissy-sur-Seine, France.
- INSERM, CNRS, Institut Cochin, Université Paris Cité, Paris, France.
ORCID-Profile: Ines S Amorim
Förderung
- Institut de Recherches Servier
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Association France Alzheimer
- Agence Nationale de la Recherche
- Fondation Philippe Chatrier
Zitieren
APA
Amorim, I. S., Challal, S., Cistarelli, L., Dorval, T., Abjean, L., Touzard, M., Arbez, N., François, A., Panayi, F., Jeggo, R., Cecon, E., Oishi, A., Dam, J., Jockers, R., & Machado, P. (2023). A seeding-based neuronal model of tau aggregation for use in drug discovery. PLOS ONE. https://doi.org/10.1371/journal.pone.0283941
Vancouver
Amorim IS, Challal S, Cistarelli L, Dorval T, Abjean L, Touzard M, et al. A seeding-based neuronal model of tau aggregation for use in drug discovery. PLOS ONE. 2023. doi:10.1371/journal.pone.0283941
BibTeX
@article{Amorim2023,
author = {Amorim, Ines S and Challal, Sylvie and Cistarelli, Laetitia and Dorval, Thierry and Abjean, Laurene and Touzard, Manuelle and Arbez, Nicolas and François, Arnaud and Panayi, Fany and Jeggo, Ross and Cecon, Erika and Oishi, Atsuro and Dam, Julie and Jockers, Ralf and Machado, Patricia},
title = {A seeding-based neuronal model of tau aggregation for use in drug discovery},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283941}
}
EUVIMED